Overview
Global leader in animal nutrition and aquafeed solutions.
Founded
1994
Deals ยท 12mo
0
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
BiomEdit | Jul 2025Participated | $20 MSeries B | |
LAXEY | Apr 2024Participated | $43 MOther Equity | |
ViAqua Therapeutics | Sep 2023Participated | $8 MOther Equity | |
Stellapps | Oct 2021Led | $18 MSeries C | |
Stellapps | Sep 2021Participated | $9 MSeries B | |
Proteon Pharmaceuticals | Aug 2021Led | $25 MOther Equity | |
ENOUGH | Jun 2021Led | $50 MSeries B | |
ViAqua Therapeutics | Jun 2021Participated | $3 MOther Equity | |
Mosa Meat | Feb 2021Participated | $10 MSeries B | |
BlueNalu | Feb 2020Participated | $20 MSeries A | |
BiomEdit | Jul 2025Participated | $20 MSeries B | |
LAXEY | Apr 2024Participated | $43 MOther Equity | |
ViAqua Therapeutics | Sep 2023Participated | $8 MOther Equity | |
Stellapps | Oct 2021Led | $18 MSeries C | |
Stellapps | Sep 2021Participated | $9 MSeries B | |
Proteon Pharmaceuticals | Aug 2021Led | $25 MOther Equity | |
ENOUGH | Jun 2021Led | $50 MSeries B | |
ViAqua Therapeutics | Jun 2021Participated | $3 MOther Equity | |
Mosa Meat | Feb 2021Participated | $10 MSeries B | |
BlueNalu | Feb 2020Participated | $20 MSeries A |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 1 |
| Series B | 1 | 3 |
| Series C+ | 1 | 0 |
| Other Equity | 1 | 3 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Feb '20 | 1 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 1 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 2 |
| Jul '21 | 0 |
| Aug '21 | 1 |
| Sep '21 | 1 |
| Oct '21 | 1 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 1 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 1 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 1 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 6 |
| Food & Agriculture | 6 |
| Networks, Cloud & Communication | 2 |
| Enterprise Software | 2 |
| Data, Analytics & IT | 2 |
| AR/VR | 1 |
| Clean Energy & Sustainability | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 2 |
| $10M-$25M | 5 |
| $25M-$50M | 2 |
| $50M-$100M | 0 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 4 of 4 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Europe | 4 |
| Israel | 2 |
| United States | 2 |
| India | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Agriline | 2 |
| CPT Capital | 2 |
| S2G | 2 |
| The Trendlines Group | 2 |
| ABB | 1 |
| ABB Technology Ventures | 1 |
| Almenni pension fund | 1 |
| Anterra Capital | 1 |
| Aqua-Spark | 1 |
| AXA IM Alts | 1 |
| Blue Future Holding | 1 |
| Blue Horizon | 1 |
| Celesta Capital | 1 |
| Circle Investments | 1 |
| Clear Current Capital | 1 |
| Festa pension fund | 1 |
| Griffith Foods | 1 |
| HAL Investments | 1 |
| IndusAge Partners | 1 |
| KBW Ventures | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 3 | 30% |
| Participating | 7 | 70% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 33% |
| Co-led | 2 | 67% |
Team
Director Global Integrated Business Planning (IBP)
Chief Financial Officer & member of the executive board
Chief Strategy Officer & Member Executive Committee
Junior Specialist Cell Nutrition
Head of Alternative Protein Program
